LLY compared with ZNTL: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ZNTLZentalis Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ZNTLZentalis Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,419.27

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ZNTLZentalis Pharmaceuticals, Inc.

1.76▼−1.12%· post 1.76

ClosedNov 4 '26

Mkt cap$127.6MRevenue$27MQ4 FY24Revenue—

Compare

ClosedNov 4 '26

LLYELI Lilly & Co

ZNTLZentalis Pharmaceuticals, Inc.

1,417.89▲+0.60%post 1,419.27

Price

1.76▼−1.12%post 1.76

$1.3T

Mkt cap

$127.6M

Q3 FY26$24.4B

Revenue

$27MQ4 FY24

FY25$65.2B

Revenue

—

LLY1,417.89▲+0.60%vsZNTL1.76▼−1.12%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ZNTL: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only ZNTL 5

PFEPfizersupplier

IMNMImmunomecustomer

GSKGSKsupplier

—Dana‑Farber Cancer Instituteunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

1 more · ZNTL chain ›

Price

rebased to 0%

LLY, solidZNTL, dashed